Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 4,558 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: obesity Clear all

Conditions: Obesity
Interventions: VI-0521, topiramate, phentermine; Drug
Lead sponsor: VIVUS LLC; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 756 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Durham, North Carolina • Philadelphia, Pennsylvania

Conditions: Overweight, Obesity
Interventions: RIDE e-health application; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Hypertension
Interventions: Orforglipron, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 974 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 29
States / cities: Phoenix, Arizona • Covina, California • Northridge, California + 24 more

Conditions: Obesity, Diabetes Mellitus, Type 2, PreDiabetes
Interventions: Intensive Lifestyle Intervention; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 40 Years to 70 Years
Enrollment: 352 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Food Selection
Interventions: White Rice, Brown Rice, Glucose; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Bottle Feeding
Interventions: Digital Health Intervention, Safety Control; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Obesity, Childhood
Interventions: Web-based comic and newsletters, Didactic health information; Behavioral
Lead sponsor: Tufts University; Other
Eligibility: 8 Years to 12 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: New York, New York • The Bronx, New York

Conditions: Weight Loss
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 3
States / cities: Phoenix, Arizona • Scottsdale, Arizona

Conditions: Obesity, Glucose Intolerance, Diabetes, Acanthosis Nigricans
Interventions: Not listed
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 8 Years to 18 Years
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Obesity
Interventions: HM11260C, Placebo; Biological
Lead sponsor: Hanmi Pharmaceutical Company Limited; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 297 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Overweight, Obese
Interventions: Motivational and Family Weight Loss, Basic Health Education, Online Intervention, Online Control; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 11 Years to 16 Years
Enrollment: 241 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Type 2 Diabetes Mellitus
Interventions: SAR425899; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 3
States / cities: Saint Paul, Minnesota • Knoxville, Tennessee • Austin, Texas

Conditions: Depression, Obesity
Interventions: Accept Yourself!, Weight Watchers; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular
Interventions: Metformin, semaglutide, Anti-hypertensives, Lipid Lowering Medication, Life style intervention, Fezolinetant, Hormonal therapy; Drug · Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 45 Years to 55 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Aurora, Colorado • Chapel Hill, North Carolina • Richmond, Virginia

Conditions: Obesity and Overweight, Breast Cancer Survivorship
Interventions: Broccoli microgreen (BMG); Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Steatohepatitis, Nonalcoholic, Hemosiderosis, Overweight Adolescents, Obesity, Childhood, Liver Steatosis
Interventions: Not listed
Lead sponsor: The Geneva Foundation; Other
Eligibility: 10 Years to 17 Years
Enrollment: 150 participants
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Type II Diabetes Mellitus
Interventions: JTT-130, JTT-130 Placebo; Drug
Lead sponsor: Shionogi Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 496 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 48
States / cities: Birmingham, Alabama • Muscle Shoals, Alabama • Scottsboro, Alabama + 45 more

Conditions: Obesity, Diabetes
Interventions: Diet and physical activity monitoring; Behavioral
Lead sponsor: Loyola University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Obesity, Metabolic Complication
Interventions: Acute Bout of Exercise; Procedure
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 20 Years to 60 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Mycoses
Interventions: Anidulafungin; Drug
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Obesity
Interventions: Combined gastric mucosal ablation with endoscopic sleeve gastroplasty; Procedure
Lead sponsor: True You Weight Loss; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Atlanta, Georgia • Cary, North Carolina

Conditions: Pediatric Obesity
Interventions: Parents as Coaches, Parent Weight Loss; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 12 Years to 16 Years
Enrollment: 162 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Henrico, Virginia

Conditions: Overweight or Obese, Type 2 Diabetes Mellitus (T2DM)
Interventions: Placebo, Enicepatide; Drug
Lead sponsor: Carmot Therapeutics, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 447 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 52
States / cities: Birmingham, Alabama • Guntersville, Alabama • Yuma, Arizona + 45 more

Conditions: Atrial Fibrillation, Obesity, Anticoagulants
Interventions: Apixaban; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 107,383 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults

Evaluation of the Remote Intervention for Diet and Exercise (RIDE)

A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)

Promoting Successful Weight Loss in Primary Care in Louisiana Using Information Technology

Satiety Response of White and Brown Rice Compared to Glucose Control

GrowWell - Responsive Bottle Feeding

Intervention INC: An Interactive Family-centered mHealth Tool to Reduce Obesity Risk in Urban Minority Preadolescents

Study of Effects From Gastric Bypass Weight Loss on Brain Tissue

Prevalence of Carbohydrate Intolerance in Lean and Obese Children

Effect of LAPS-Exendin on Body Weight in Obese Population

Families Improving Together (FIT) for Weight Loss

A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period

Health At Every Size and Acceptance and Commitment Therapy vs. Behavioral Weight Loss for Obesity and Depression in Women

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors

The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients

Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

Gut Microbiota, Short Chain Fatty Acids, and Adiposity Across The Epidemiological Transition

Effects of a Single Bout of Exercise on Transcriptomics and Metabolomics in Adipose Tissue

Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations

Ablation Registry (Combined Gastric Mucosal Ablation With Endoscopic Sleeve Gastroplasty for Weight Loss)

The Role of Parents in Adolescent Obesity Treatment

A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare